openPR Logo
Press release

Rising incidences of chronic inflammatory and autoimmune diseases has increased the need of anti-inflammatory therapeutics Market

01-03-2019 07:37 PM CET | Health & Medicine

Press release from: Allied Market Research

Rising incidences of chronic inflammatory and autoimmune

According to a new report published by apacmarket.com, titled, Anti-inflammatory Therapeutics Asia-Pacific Market Research Report, 2014-2020, the Asia-Pacific anti-inflammatory therapeutics market is expected to grow at a CAGR of 8.6% during the period of 2015-2020. The arthritis segment would continue to lead the Asia Pacific anti-inflammatory therapeutics market through 2020. China anti-inflammatory therapeutics market is forecast to grow at the highest CAGR of 13.9% during the forecast period.

Get the sample Report: https://www.alliedmarketresearch.com/request-sample/1175?utm_source=openpr_Niranjan

Inflammation is a nonspecific immune defense mechanism of the body triggered due to injuries, bacterial or viral infections or any damage to the internal or external organs. When this inflammation persists for longer duration it can lead to chronic diseases such as atherosclerosis and rheumatoid arthritis, to name few. Currently, reduction of inflammation particularly in chronic diseases is the widely accepted therapeutic approach adopted by physicians.

Rising incidences of autoimmune and respiratory diseases, increasing R&D investments in China and India and a large number of biosimilar drugs in the development pipeline would drive the growth of the Asia-Pacific anti-inflammatory therapeutics market. Furthermore, factors such as the existence of established markets for NSAIDs and corticosteroids, large adoption of OTC (over the counter) NSAIDs, such as ibuprofen and naproxen, in China and India and government initiatives in the Asia-Pacific region would further boost the market growth. However, the adverse effects associated with prolonged consumption of drugs such as NSAIDs and corticosteroids and issues of uncertain patent legislation, such as compulsory licensing in India, would limit market growth. High price sensitivity in countries such as India and China would be the key challenge for drug innovators to launch their patented drugs in the market.

Purchase the Report @ Discount: https://www.alliedmarketresearch.com/checkout/180310?utm_source=openpr_Niranjan

The anti-inflammatory biologics segment dominated the market in 2014 and is expected to display the highest growth rate over the forecast period. This is due to the unmatched benefits offered by biological drugs and rapid adoption in countries like Japan along with improving healthcare access and increasing healthcare expenditures. The popularity of corticosteroids has been decreasing due to the issues of withdrawal symptoms and toxicity.

Key Findings of the Anti-inflammatory Therapeutics Asia-Pacific Market:

China is expected to take over Japan by 2018 in the Asia Pacific anti-inflammatory therapeutics market. India anti-inflammatory therapeutics market is projected to account for around 13% share in the Asia-Pacific market by 2020. China and India would govern around half of the Asia-Pacific NSAID market by 2020. Japan accounted for around 1/3rd share in the anti-inflammatory biologics market in 2014, the highest among all Arthritis indication was the major revenue-generating segment in the APAC anti-inflammatory indication market in 2014. Psoriasis indication is projected to grow at a CAGR of 10.7%, fastest among all indications.

Japan is the leading market for patented as well as biologic drugs. However, a government in Japan is now focusing on the establishment of effective generic drugs. On the other hand, China is projected to emerge as the new market leader in the Asia-Pacific anti-inflammatory therapeutics market by 2020 due to the rapidly developing economy, growing healthcare expenditure and huge patient base. In India, the launch of biosimilars and constantly improving per capita healthcare spending would be the key factors facilitating the growth of anti-inflammatory therapeutics market.

Companies have been adopting strategies such as collaborations, indication expansions, and product launches as their key strategies to overcome the patent expiry issues of existing drugs and to gain additional market share. The key companies profiled in this report are Pfizer, Inc., AbbVie, Inc., Johnson & Johnson, GlaxoSmithKline plc, Merck & CO., Inc. Novartis AG, F. Hoffman La Roche AG, Eli Lily and Company, AstraZeneca PLC and Amgen, Inc.

About Us:-

Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact Us:-

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rising incidences of chronic inflammatory and autoimmune diseases has increased the need of anti-inflammatory therapeutics Market here

News-ID: 1469578 • Views:

More Releases from Allied Market Research

Luxury Hotel Market Huge Demand, High Growth Rate to Reach $160.4812 Billion by 2031, At a CAGR of 5.1% From 2020-2031
Luxury Hotel Market Huge Demand, High Growth Rate to Reach $160.4812 Billion by …
According to a new report published by Allied Market Research, titled, "Luxury Hotel Market by Type, by Category: Global Opportunity Analysis and Industry Forecast, 2020-2031". The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and changing market trends. The global luxury hotel market was valued at $95,113.00 million in 2020, and is projected to reach $160,481.23
Luxury Hotel Market Huge Demand, High Growth Rate to Reach $160.4812 Billion by 2031, At a CAGR of 5.1% From 2020-2031
Luxury Hotel Market Huge Demand, High Growth Rate to Reach $160.4812 Billion by …
According to a new report published by Allied Market Research, titled, "Luxury Hotel Market by Type, by Category: Global Opportunity Analysis and Industry Forecast, 2020-2031". The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and changing market trends. The global luxury hotel market was valued at $95,113.00 million in 2020, and is projected to reach $160,481.23
Why Invest in Augmented Reality Market Share Reach USD 411.4 Billion by 2031, Growing at a CAGR of 33.2%
Why Invest in Augmented Reality Market Share Reach USD 411.4 Billion by 2031, Gr …
According to the report published by Allied Market Research, Why Invest in Augmented Reality Market Share Reach USD 411.4 Billion by 2031, Growing at a CAGR of 33.2%. The report provides an extensive analysis of changing market dynamics, major segments, value chain, competitive scenario, and regional landscape. This research offers valuable able guidance to leading players, investors, shareholders, and startups in devising strategies for sustainable growth and gaining a competitive
Why Invest in Data Extraction Market Size Reach USD 4.90 Billion by 2027
Why Invest in Data Extraction Market Size Reach USD 4.90 Billion by 2027
According to the report published by Allied Market Research, Why Invest in Data Extraction Market Size Reach USD 4.90 Billion by 2027. The report provides an extensive analysis of changing market dynamics, major segments, value chain, competitive scenario, and regional landscape. This research offers valuable able guidance to leading players, investors, shareholders, and startups in devising strategies for sustainable growth and gaining a competitive edge in the market. Rise in adoption

All 5 Releases


More Releases for Asia

South East Asia Business Jet Market And Top Key Players are Asia Corporate Jet, …
By 2022, the South East Asia Business Jet Markets estimated to reach US$ XX Mn, up from US$ XX Mn in 2016, growing at a CAGR of XX% during the forecast period. The Global Business Jet Market, currently at 21 million USD, contributes the highest share in the market and is poised to grow at the fastest rate in the future. The three broad categories of business jets are Small,
RAMPF Korea – Producing in Asia for Asia
Joint Venture for the Asian markets – The international RAMPF Group has realigned the cooperation with its long-standing partner Orient Dosiertechnik from Korea with the founding of RAMPF Korea Co., Ltd. The new company based in Hwaseong City is developing and producing mixing and dispensing systems specifically for the Asian markets. Within the framework of the new joint venture based in Hwaseong City, mixing and dispensing systems are being developed and
LIXIL Asia Presents Asia Pacific Property Awards
Through its power brands GROHE and American Standard, LIXIL Asia signs a three-year deal to become the Headline Sponsor of the Asia Pacific Property Awards from 2019 until 2022. 23rd January 2019: The International Property Awards, first established in 1993, are open to residential and commercial property professionals from around the globe. They celebrate the highest levels of achievement by companies operating within the architecture, interior design, real estate and property
PEOPLEWAVE WINS ASIA TECH PODCAST PITCHDECK ASIA 2019 AWARDS
15 January 2019, Singapore – Peoplewave, Asia’s leading data-driven HR technology company, won the Asia Tech Podcast (ATP) Pitchdeck Asia 2019 Awards, being awarded “Startup Most Likely to Succeed in 2019". The 2019 Pitchdeck Asia Awards is an opportunity for the Asian Startup Ecosystem to shine a spotlight on some of its best startups. The awards were decided by a public vote. More than 7,200 votes were cast by registered LinkedIn
Undersea Defence Technology Asia, UDT Asia 2011
Latest Military Diving Technologies featured in UDT Asia Equipping Asia’s navies with the latest diving technology for asymmetric warfare and operations SINGAPORE, 17 October 2011 - Naval diving and underwater special operations is a field that is seeing increased attention and investment amongst navies in Asia. Units such as the Indonesian Navy‟s KOPASKA, the Republic of Singapore Navy‟s Naval Diving Unit (NDU), the Royal Malaysian Navy‟s PASKAL are increasingly utilising specialised equipment for conducting
Asia Diligence – Specialist Investigative Due Diligence for Asia & Beyond
Asia Diligence today announced the opening of its European Customer Services office in the United Kingdom. The office is to be managed by Steve Fowler and will focus on providing services to Asia Diligence’s European customers. Asia Diligence is also planning to open a US office in the near future, which will provide customer service to its US and North American clients. Asked to comment on the move, Luke Palmer, the